The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBPET.L Regulatory News (BPET)

  • There is currently no data for BPET

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

1st Quarter Results

27 May 2015 11:37

RNS Number : 3579O
F&C Private Equity Trust PLC
27 May 2015
 



 

To: Stock Exchange

For immediate release:

27 May 2015

 

F&C Private Equity Trust plc

Quarterly results for the three months to 31 March 2015 (unaudited) 

· Share price total return for the three months of 4.9 per cent for the Ordinary Shares.

· NAV total return for the three months of -0.7 per cent for the Ordinary Shares.

· Strong deal flow in funds and co-investments.

 

 

 

Manager's Review

 

Introduction

At 31 March 2015 the net asset value ('NAV') of the Company was £202.0 million, giving a fully diluted NAV per ordinary share of 275.49p, a decrease of 0.7 per cent over the quarter. The Company had net debt of £29.0 million giving gearing of 12.6 per cent. Outstanding undrawn commitments stood at £58.2 million at the end of the period and, of this, approximately £17 million is to funds where the investment period has expired and hence only a small proportion of this amount is expected to be drawn.

 

New Investments and Drawdowns

The total amount invested through drawdowns from funds and co-investments during the first quarter was £12.4 million. Three new investments were made; one primary fund commitment, one advanced primary investment and one co-investment. €5 million was committed to Iberian fund Corpfin IV. This leading Spanish mid-market specialist has come through the recession well and is well placed to acquire companies as the economies of Spain and Portugal continue to recover. Also aiming to capture some attractive investment opportunities in Southern Europe, we committed €4 million to Italian fund Aliante 3. This fund has been established for three years and already has four companies in its portfolio, giving unusually good visibility and immediate maturity to the portfolio. The managers, who are based in Milan, have particular expertise in the food and beverage sectors of the Italian mid-market. A new co-investment has also been added to the portfolio: £4.5 million has been invested for a 28 per cent stake in Dover-based Burgess Marine. This deal, which was led by RJD Partners, gives the Company exposure to a fast growing marine engineering services company. Burgess Marine has three main businesses: refitting of commercial and naval vessels; boat building for shallow draft workboats and wind farm support vessels; and refitting superyachts. Each of these sections is experiencing good growth.

 

There have been several fund drawdowns for new investments. These are for a typically diverse range of new investments. Inflexion called a total of £1.4 million from their 2010 Fund and 2012 Co-investment Fund for investment in luxury travel agency Scott Dunn. The upper end of the holiday market has shown strong growth characteristics in recent years. £0.5 million has been invested into the Agilitas led co-investment in damage control services company Recover Nordic for an add-on acquisition in Sweden. In Germany, DBAG VI called £0.4 million for iron foundry company Geinanth which specialises in casting engine blocks for large diesel and gas engines.

 

Realisations

The strong flow of realisations experienced in 2014 appears to have continued into this year with a total of £10.8 million coming in during the first quarter.

 

The largest single realisation was £2.7 million from pallet racking system company Whittan. This company was severely impacted by the recession but it was refinanced and recovered fairly strongly such that the combined original cost of the investment was recovered when it was sold to European private equity house Bregal after an eight year hold. There were a handful of other significant exits in the UK. Piper Private Equity IV sold Rollover Holdings, the UK's leading food service hotdog company, to Kerry Group plc, achieving a 2.5x multiple with proceeds of £0.8 million. Inflexion sold Aspen Pumps from their 2006 Fund returning £0.7 million which represents a hugely impressive multiple of 14.0x cost and an IRR of over 40 per cent. There is potential for this to improve further as Inflexion retains a stake in the acquirer, CP Electronics. Inflexion also returned £0.7 million from their 2010 Fund and 2012 Co-investment Fund from the refinancing of Marston's, the UK's leading debt enforcement business. Hutton Collins III returned £0.5 million from the refinancing of UK restaurant chain Wagamama. This represents 1.9x cost and an IRR of 18 per cent. As the fund still retains an equity stake the return could increase further. TDR Capital II returned £0.3 million from the refinancing of its pub chain company Stonegate where the company has undertaken a sale and leaseback of some of its properties.

 

Life Science Partners, the Netherlands based specialist venture capitalist, returned £1.7 million as part of the proceeds from the sale of Prosensa, the pharmaceutical company specialising in RNA modulating therapeutics with applications in certain genetic diseases such as Duchenne muscular dystrophy. In Eastern Europe, Accession Mezzanine II distributed £0.7 million as proceeds from the sale of Polish metallic enhancement company Norican, which was sold to Altor, a Nordic buy-out house. This investment had a challenging time during the recession and the ultimate outcome was for a small premium to cost. In the Company's small US portfolio, £0.4 million came in from US mid-market fund of funds RCP II after the fund realised some of its remaining holdings via a secondary transaction. The very longstanding holding in Hicks Muse Tate & Furst IV distributed £0.5 million as a result of the merger of LIN Media with Media General. The fund retains shares in the latter company and these have appreciated in value since the deal.

 

Valuation Changes

The first quarter is traditionally a quiet one for valuation movements with the valuation point falling less than two months after the full year valuation is confirmed. Notable movements included a £0.7 million uplift for the Inflexion led co-investment SMD Hydrovision, which has now been sold to Chinese buyer ZhouZou CSR. Proceeds of £8.3 million were received in April and this is reflected in the valuation. We had incorporated a small discount to the expected proceeds in the year end valuation pending receipt of the funds. This seven year hold has achieved a multiple of 2.1x cost and an IRR of 11 per cent. Other uplifts reflect realisations or uplifts based on improved trading. Hutton Collins III is up by £0.3 million, Blue Point Capital II by £0.4 million, Gilde Buyout III by £0.4 million and Hicks Muse Tate & Furst IV by £0.6 million.

 

There have also been some downgrades. Blues Clothing, the character licensing textiles company was sold after the quarter end at a disappointing price, representing a multiple of 0.2x cost; there was a £0.2 million downgrade in the valuation to reflect this and a further £0.2 million downgrade from the Penta fund, in which it is also held. Once again, there has been an adverse influence from currency movements. This is mainly Euro weakness with a decrease of over 7 per cent against sterling over the quarter. The US Dollar appreciated by almost the same amount which offset some of the impact, as did the Company's Euro-denominated debt, resulting in a net effect on the Company's NAV of just over 1 per cent.

 

Financing

Since the quarter end, the Company has received the proceeds of the SMD Hydrovision sale of £8.3 million and several other smaller realisations, such that the current level of net debt is £26.2 million (as at 27 May 2015). This gives considerable capacity to make further investments. As the year progresses, the competitive terms on which the Company is borrowing compared with its previous borrowing via zero dividend preference shares will become noticeable and this, coupled with the partial hedging benefits from the Euro-denominated debt noted above, are helpful features.

 

Outlook

There is a strong flow of fund and co-investment opportunities at present and we are selectively participating in this. Anecdotal evidence and headline pricing statistics indicate that in some areas value is difficult to find, however our investment partners are on the whole finding attractive deals without paying dangerously high prices. Our co-investment dealflow is also reasonably priced. There remain serious issues in parts of the Eurozone that need to be addressed, but much of this is well understood and factored into the prices paid by private equity specialists. Expectations of management are for continued economic growth this year with very low inflation, low interest rates and improving public finances. The relatively buoyant conditions of the recent past are expected to continue and this should prove positive for private equity activity, for value creation and returns for your Company.

 

 

 

Hamish Mair

Investment Manager

F&C Investment Business Limited

 

 

F&C PRIVATE EQUITY TRUST PLC

 

Statement of Comprehensive Income for the

three months ended 31 March 2015 (unaudited)

 

 

Revenue

£'000

Capital

£'000

Total

£'000

 

Income

Losses on investments held at fair value

-

(2,984)

(2,984)

Exchange gains

-

2,546

2,546

Investment income

19

-

19

Other income

4

-

4

Total income

23

(438)

(415)

Expenditure

Investment management fee - basic fee

(123)

(371)

(494)

Investment management fee - performance fee

-

-

-

Other expenses

(168)

-

(168)

Total expenditure

(291)

(371)

(662)

Loss before finance costs and taxation

(268)

(809)

(1,077)

Finance costs

(113)

(340)

(453)

Loss before taxation

(381)

(1,149)

(1,530)

Taxation

-

-

-

Loss for period/total comprehensive income

(381)

(1,149)

(1,530)

Return per Ordinary Share - Basic

(0.53)p

(1.59)p

(2.12)p

Return per Ordinary Share - Fully diluted

(0.51)p

(1.55)p

(2.06)p

 

 

 

F&C PRIVATE EQUITY TRUST PLC

 

Consolidated Statement of Comprehensive Income for the

three months ended 31 March 2014 (unaudited)

 

 

 

 

 

Revenue

£'000

Capital

£'000

Total

£'000

 

Income

Losses on investments held at fair value

-

(1,208)

(1,208)

Exchange gains

-

73

73

Investment income

1,611

-

1,611

Other income

6

-

6

Total income

1,617

(1,135)

482

Expenditure

Investment management fee - basic fee

(131)

(392)

(523)

Investment management fee - performance fee

-

-

-

Other expenses

(129)

-

(129)

Total expenditure

(260)

(392)

(652)

Profit/(loss) before finance costs and taxation

1,357

(1,527)

(170)

Finance costs

(69)

(1,164)

(1,233)

Profit/(loss) before taxation

1,288

(2,691)

(1,403)

Taxation

(296)

296

-

Profit/(loss) for period/total comprehensive income

992

(2,395)

(1,403)

Return per Ordinary Share - Basic

1.37p

(3.31)p

(1.94)p

Return per Ordinary Share - Fully diluted

1.34p

(3.23)p

(1.89)p

F&C PRIVATE EQUITY TRUST PLC

 

Consolidated Statement of Comprehensive Income for the

year ended 31 December 2014 (audited)

 

 

Revenue

£'000

Capital

£'000

Total

£'000

 

Income

Gains on investments held at fair value

-

18,587

18,587

Exchange gains

-

572

572

Investment income

3,972

-

3,972

Other income

27

-

27

Total income

3,999

19,159

23,158

Expenditure

Investment management fee - basic fee

(516)

(1,548)

(2,064)

Investment management fee - performance fee

-

(1,085)

(1,085)

Other expenses

(745)

-

(745)

Total expenditure

(1,261)

(2,633)

(3,894)

Profit before finance costs and taxation

2,738

16,526

19,264

Finance costs

(349)

(4,854)

(5,203)

Profit before taxation

2,389

11,672

14,061

Taxation

(451)

451

-

Profit for year/total comprehensive income

1,938

12,123

14,061

Return per Ordinary Share - Basic

2.68p

16.77p

19.45p

Return per Ordinary Share - Fully diluted

2.61p

16.33p

18.94p

 

 

F&C PRIVATE EQUITY TRUST PLC

 

Balance Sheet

 

 

 

As at 31 March 2015

As at 31 March 2014

As at 31 December 2014

(unaudited)

(unaudited)

(audited)

£'000

£'000

 £'000

Non-current assets

Investments at fair value through profit or loss

233,441

231,431

234,414

Current assets

Other receivables

36

299

2,577

Cash and short-term deposits

6,268

9,493

6,946

6,304

9,792

9,523

Current liabilities

Other payables

(16,979)

(2,618)

(18,117)

Zero dividend preference shares

-

(42,791)

-

Net current liabilities

(10,675)

(35,617)

(8,594)

Total assets less current liabilities

222,766

195,814

225,820

Non-current liabilities

Interest-bearing bank loan

(20,788)

-

(22,312)

Net assets

201,978

195,814

203,508

Equity

Called-up ordinary share capital

723

723

723

Special distributable capital reserve

15,679

15,679

15,679

Special distributable revenue reserve

31,403

31,403

31,403

Capital redemption reserve

1,335

1,335

1,335

Capital reserve

148,620

143,021

149,769

Revenue reserve

4,218

3,653

4,599

Shareholders' funds

201,978

195,814

203,508

Net asset value per Ordinary Share - Basic

279.43p

270.90p

281.55p

Net asset value per Ordinary Share - Fully diluted

 

275.49p

 

267.18p

 

277.55p

 

F&C PRIVATE EQUITY TRUST PLC

Reconciliation of Movements in Shareholders' Funds

 

 

 

 

 

Three months ended 31 March 2015

Three months ended 31 March 2014

Year ended 31 December 2014

 

(unaudited)

(unaudited)

(audited)

 

£'000

£'000

£'000

Opening shareholders' funds

203,508

197,217

197,217

(Loss)/profit for the period/total comprehensive income

(1,530)

(1,403)

14,061

Dividends paid

-

-

(7,770)

Closing shareholders' funds

201,978

195,814

203,508

 

 Notes (unaudited)

 

1. The unaudited quarterly results have been prepared on the basis of the accounting policies set out in the statutory accounts of the Company for the year ended 31 December 2014. The Company's wholly owned subsidiary, F&C Private Equity Zeros plc, entered into voluntary members liquidation on 12 December 2014. Consolidation accounts have not been prepared for the current period on the basis that control was transferred out of the Group on 12 December 2014.

 

2. Investment management fee:

 

 

 

Three months ended

31 March 2015

 

 

Three months ended

 31 March 2014

 

 

Year ended

31 December 2014

 

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

 

 

 

 

 

 

 

 

 

 

Investment managementfee - basic fee

 

123

 

371

 

494

 

131

 

392

 

523

 

516

 

1,548

 

2,064

Investment management fee - performance fee

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

1,085

 

1,085

 

 

123

 

371

 

494

 

131

 

392

 

523

 

516

 

2,633

 

3,149

 

 

 

 

 

 

 

 

 

 

 

3. Finance costs:

 

 

 

Three months ended

31 March 2015

 

 

Three months ended

 31 March 2014

 

 

Year ended

31 December 2014

 

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

 

 

 

 

 

 

 

 

 

 

Interest payable on bank loans and overdrafts

113

340

453

69

208

277

349

1,047

1,396

Finance costs attributable to ZDP Shares

-

-

-

-

956

956

-

3,807

3,807

 

113

340

453

69

1,164

1,233

349

4,854

5,203

 

4. The basic return per Ordinary Share is based on a net loss on ordinary activities after taxation of £1,530,000 (31 March 2014 - loss £1,403,000; 31 December 2014 - profit £14,061,000) and on 72,282,273 (31 March 2014 - 72,282,273; 31 December 2014 - 72,282,273) shares, being the weighted average number of Ordinary Shares in issue during the period.

 

The fully diluted return per Ordinary Share is based on a net loss on ordinary activities after taxation of £1,530,000 (31 March 2014 - loss £1,403,000; 31 December 2014 - profit £14,061,000) and on 74,241,429 (31 March 2014 - 74,241,429; 31 December 2014 - 74,241,429) shares, being the weighted average number of Ordinary Shares in issue during the period after conversion of the Ordinary Share warrants.

 

 

5. The basic net asset value per Ordinary Share is based on net assets at the period end of £201,978,000 (31 March 2014 - £195,814,000; 31 December 2014 - £203,508,000) and on 72,282,273 (31 March 2014 - 72,282,273; 31 December 2014 - 72,282,273) shares, being the number of Ordinary Shares in issue at the period end.

 

The fully diluted net asset value per Ordinary Share is based on net assets at the period end of £204,524,000 (31 March 2014 - £198,360,000; 31 December 2014 - £206,054,000) and on 74,241,429 (31 March 2014 - 74,241,429; 31 December 2014 - 74,241,429) shares, being the number of Ordinary Shares in issue at the period end after conversion of the Ordinary Share warrants.

 

 

6. The financial information for the three months ended 31 March 2015, which has not been audited or reviewed by the Company's auditor, comprises non-statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2014, on which the auditor issued an unqualified report, will be lodged with the Registrar of Companies. The quarterly report is available on the Company's website www.fcpet.co.uk.

 

For more information, please contact:

 

Hamish Mair

0131 718 1184

Gordon Hay Smith

0131 718 1018

F&C Investment Business Limited

hamish.mair@fandc.com / gordon.haysmith@fandc.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRFEAESXAAPSEFF
Date   Source Headline
30th Jun 20223:22 pmRNSChange of Name
17th Jun 20224:07 pmRNSTransaction in Own Shares
15th Jun 20225:01 pmRNSTransaction in Own Shares
27th May 20229:08 amRNSResult of Annual Gen Meeting & Directorate Change
26th May 202212:02 pmRNS1st Quarter Results
27th Apr 202210:07 amRNSDirector/PDMR Shareholding
27th Apr 202210:06 amRNSDirector/PDMR Shareholding
27th Apr 202210:04 amRNSDirector/PDMR Shareholding
26th Apr 20223:24 pmRNSDirector/PDMR Shareholding
26th Apr 20223:23 pmRNSDirector/PDMR Shareholding
25th Apr 20229:24 amRNSDirector/PDMR Shareholding
8th Apr 20227:00 amRNSAnnual Financial Report
1st Apr 202210:17 amRNSHolding(s) in Company
1st Apr 202210:09 amRNSHolding(s) in Company
30th Mar 20222:56 pmRNSDirector/PDMR Shareholding
30th Mar 20222:54 pmRNSDirector/PDMR Shareholding
25th Mar 20227:00 amRNSAnnual Financial Report
17th Feb 20227:00 amRNSDirectorate Change
14th Jan 20227:00 amRNSUpdate on Secondary Placing
13th Jan 20227:00 amRNSProposed Secondary Placing
4th Jan 20227:00 amRNSInvestor Presentation
26th Nov 20217:00 amRNS3rd Quarter Results
22nd Nov 202110:47 amRNSHolding(s) in Company
15th Oct 20219:55 amRNSHolding(s) in Company
15th Oct 20217:00 amRNSKepler Trust Intelligence: New Research
27th Aug 20217:00 amRNSInterim results and Quarterly Dividend
25th Jun 20213:14 pmRNSHolding(s) in Company
27th May 20212:15 pmRNSAGM Statement
27th May 202111:51 amRNSQuarterly NAV and Dividend Announcement
29th Apr 20211:01 pmRNSHolding(s) in Company
19th Apr 20217:00 amRNSAnnual Financial Report
26th Mar 20217:00 amRNSFinal Results
24th Mar 20217:00 amRNSInvestment Update
8th Feb 20213:00 pmRNSHolding(s) in Company
9th Dec 20209:22 amRNSHolding(s) in Company
27th Nov 202010:52 amRNSHolding(s) in Company
25th Nov 20209:18 amRNSKepler Trust Intelligence: New Research
20th Nov 20207:00 amRNSQuarterly results and dividend announcement
15th Oct 20204:09 pmRNSNon-Executive Director Declaration
18th Sep 20202:09 pmRNSDirector/PDMR Shareholding
16th Sep 20202:24 pmRNSDirector/PDMR Shareholding
15th Sep 20203:42 pmRNSHolding(s) in Company
1st Sep 202012:24 pmRNSDirector/PDMR Shareholding
21st Aug 20207:00 amRNSInterim Results
20th Jul 20207:00 amRNSNon-Executive Director Declaration
17th Jul 20207:00 amRNSAppointment of Corporate Broker
9th Jun 20209:57 amRNSHolding(s) in Company
4th Jun 20207:00 amRNSDirectorate Change
22nd May 20204:11 pmRNSHolding(s) in Company
21st May 20207:00 amRNSFirst Quarter Results and Dividend Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.